Trajectories of Glycemic Change in a National Cohort of Adults with Previously Controlled Type 2 Diabetes

Rozalina McCoy, Che Ngufor, Holly K. Van Houten, Brian Caffo, Nilay D Shah

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Individualized diabetes management would benefit from prospectively identifying well-controlled patients at risk of losing glycemic control. Objectives: To identify patterns of hemoglobin A 1c (HbA 1c) change among patients with stable controlled diabetes. Research Design: Cohort study using OptumLabs Data Warehouse, 2001-2013. We develop and apply a machine learning framework that uses a Bayesian estimation of the mixture of generalized linear mixed effect models to discover glycemic trajectories, and a random forest feature contribution method to identify patient characteristics predictive of their future glycemic trajectories. Subjects: The study cohort consisted of 27,005 US adults with type 2 diabetes, age 18 years and older, and stable index HbA 1c <7.0%. Measures: HbA 1c values during 24 months of observation. Results: We compared models with k=1, 2, 3, 4, 5 trajectories and baseline variables including patient age, sex, race/ethnicity, comorbidities, medications, and HbA 1c. The k=3 model had the best fit, reflecting 3 distinct trajectories of glycemic change: (T1) rapidly deteriorating HbA 1c among 302 (1.1%) youngest (mean, 55.2 y) patients with lowest mean baseline HbA 1c, 6.05%; (T2) gradually deteriorating HbA 1c among 902 (3.3%) patients (mean, 56.5 y) with highest mean baseline HbA 1c, 6.53%; and (T3) stable glycemic control among 25,800 (95.5%) oldest (mean, 58.5 y) patients with mean baseline HbA 1c 6.21%. After 24 months, HbA 1c rose to 8.75% in T1 and 8.40% in T2, but remained stable at 6.56% in T3. Conclusions: Patients with controlled type 2 diabetes follow 3 distinct trajectories of glycemic control. This novel application of advanced analytic methods can facilitate individualized and population diabetes care by proactively identifying high risk patients.

Original languageEnglish (US)
Pages (from-to)956-964
Number of pages9
JournalMedical Care
Volume55
Issue number11
DOIs
StatePublished - 2017

Fingerprint

Hemoglobin A
Type 2 Diabetes Mellitus
Cohort Studies
Comorbidity
Research Design
Observation

Keywords

  • diabetes mellitus type 2
  • glycosylated hemoglobin
  • machine learning
  • mixture of generalized linear mixed effects model (MGLMM)
  • patient-centered medicine
  • random forest feature contribution (rfFC) method

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Trajectories of Glycemic Change in a National Cohort of Adults with Previously Controlled Type 2 Diabetes. / McCoy, Rozalina; Ngufor, Che; Van Houten, Holly K.; Caffo, Brian; Shah, Nilay D.

In: Medical Care, Vol. 55, No. 11, 2017, p. 956-964.

Research output: Contribution to journalArticle

@article{6b6de333bafe4b358a5d7f01229adad7,
title = "Trajectories of Glycemic Change in a National Cohort of Adults with Previously Controlled Type 2 Diabetes",
abstract = "Background: Individualized diabetes management would benefit from prospectively identifying well-controlled patients at risk of losing glycemic control. Objectives: To identify patterns of hemoglobin A 1c (HbA 1c) change among patients with stable controlled diabetes. Research Design: Cohort study using OptumLabs Data Warehouse, 2001-2013. We develop and apply a machine learning framework that uses a Bayesian estimation of the mixture of generalized linear mixed effect models to discover glycemic trajectories, and a random forest feature contribution method to identify patient characteristics predictive of their future glycemic trajectories. Subjects: The study cohort consisted of 27,005 US adults with type 2 diabetes, age 18 years and older, and stable index HbA 1c <7.0{\%}. Measures: HbA 1c values during 24 months of observation. Results: We compared models with k=1, 2, 3, 4, 5 trajectories and baseline variables including patient age, sex, race/ethnicity, comorbidities, medications, and HbA 1c. The k=3 model had the best fit, reflecting 3 distinct trajectories of glycemic change: (T1) rapidly deteriorating HbA 1c among 302 (1.1{\%}) youngest (mean, 55.2 y) patients with lowest mean baseline HbA 1c, 6.05{\%}; (T2) gradually deteriorating HbA 1c among 902 (3.3{\%}) patients (mean, 56.5 y) with highest mean baseline HbA 1c, 6.53{\%}; and (T3) stable glycemic control among 25,800 (95.5{\%}) oldest (mean, 58.5 y) patients with mean baseline HbA 1c 6.21{\%}. After 24 months, HbA 1c rose to 8.75{\%} in T1 and 8.40{\%} in T2, but remained stable at 6.56{\%} in T3. Conclusions: Patients with controlled type 2 diabetes follow 3 distinct trajectories of glycemic control. This novel application of advanced analytic methods can facilitate individualized and population diabetes care by proactively identifying high risk patients.",
keywords = "diabetes mellitus type 2, glycosylated hemoglobin, machine learning, mixture of generalized linear mixed effects model (MGLMM), patient-centered medicine, random forest feature contribution (rfFC) method",
author = "Rozalina McCoy and Che Ngufor and {Van Houten}, {Holly K.} and Brian Caffo and Shah, {Nilay D}",
year = "2017",
doi = "10.1097/MLR.0000000000000807",
language = "English (US)",
volume = "55",
pages = "956--964",
journal = "Medical Care",
issn = "0025-7079",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Trajectories of Glycemic Change in a National Cohort of Adults with Previously Controlled Type 2 Diabetes

AU - McCoy, Rozalina

AU - Ngufor, Che

AU - Van Houten, Holly K.

AU - Caffo, Brian

AU - Shah, Nilay D

PY - 2017

Y1 - 2017

N2 - Background: Individualized diabetes management would benefit from prospectively identifying well-controlled patients at risk of losing glycemic control. Objectives: To identify patterns of hemoglobin A 1c (HbA 1c) change among patients with stable controlled diabetes. Research Design: Cohort study using OptumLabs Data Warehouse, 2001-2013. We develop and apply a machine learning framework that uses a Bayesian estimation of the mixture of generalized linear mixed effect models to discover glycemic trajectories, and a random forest feature contribution method to identify patient characteristics predictive of their future glycemic trajectories. Subjects: The study cohort consisted of 27,005 US adults with type 2 diabetes, age 18 years and older, and stable index HbA 1c <7.0%. Measures: HbA 1c values during 24 months of observation. Results: We compared models with k=1, 2, 3, 4, 5 trajectories and baseline variables including patient age, sex, race/ethnicity, comorbidities, medications, and HbA 1c. The k=3 model had the best fit, reflecting 3 distinct trajectories of glycemic change: (T1) rapidly deteriorating HbA 1c among 302 (1.1%) youngest (mean, 55.2 y) patients with lowest mean baseline HbA 1c, 6.05%; (T2) gradually deteriorating HbA 1c among 902 (3.3%) patients (mean, 56.5 y) with highest mean baseline HbA 1c, 6.53%; and (T3) stable glycemic control among 25,800 (95.5%) oldest (mean, 58.5 y) patients with mean baseline HbA 1c 6.21%. After 24 months, HbA 1c rose to 8.75% in T1 and 8.40% in T2, but remained stable at 6.56% in T3. Conclusions: Patients with controlled type 2 diabetes follow 3 distinct trajectories of glycemic control. This novel application of advanced analytic methods can facilitate individualized and population diabetes care by proactively identifying high risk patients.

AB - Background: Individualized diabetes management would benefit from prospectively identifying well-controlled patients at risk of losing glycemic control. Objectives: To identify patterns of hemoglobin A 1c (HbA 1c) change among patients with stable controlled diabetes. Research Design: Cohort study using OptumLabs Data Warehouse, 2001-2013. We develop and apply a machine learning framework that uses a Bayesian estimation of the mixture of generalized linear mixed effect models to discover glycemic trajectories, and a random forest feature contribution method to identify patient characteristics predictive of their future glycemic trajectories. Subjects: The study cohort consisted of 27,005 US adults with type 2 diabetes, age 18 years and older, and stable index HbA 1c <7.0%. Measures: HbA 1c values during 24 months of observation. Results: We compared models with k=1, 2, 3, 4, 5 trajectories and baseline variables including patient age, sex, race/ethnicity, comorbidities, medications, and HbA 1c. The k=3 model had the best fit, reflecting 3 distinct trajectories of glycemic change: (T1) rapidly deteriorating HbA 1c among 302 (1.1%) youngest (mean, 55.2 y) patients with lowest mean baseline HbA 1c, 6.05%; (T2) gradually deteriorating HbA 1c among 902 (3.3%) patients (mean, 56.5 y) with highest mean baseline HbA 1c, 6.53%; and (T3) stable glycemic control among 25,800 (95.5%) oldest (mean, 58.5 y) patients with mean baseline HbA 1c 6.21%. After 24 months, HbA 1c rose to 8.75% in T1 and 8.40% in T2, but remained stable at 6.56% in T3. Conclusions: Patients with controlled type 2 diabetes follow 3 distinct trajectories of glycemic control. This novel application of advanced analytic methods can facilitate individualized and population diabetes care by proactively identifying high risk patients.

KW - diabetes mellitus type 2

KW - glycosylated hemoglobin

KW - machine learning

KW - mixture of generalized linear mixed effects model (MGLMM)

KW - patient-centered medicine

KW - random forest feature contribution (rfFC) method

UR - http://www.scopus.com/inward/record.url?scp=85031817336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031817336&partnerID=8YFLogxK

U2 - 10.1097/MLR.0000000000000807

DO - 10.1097/MLR.0000000000000807

M3 - Article

VL - 55

SP - 956

EP - 964

JO - Medical Care

JF - Medical Care

SN - 0025-7079

IS - 11

ER -